Shah Preetam

Track

Insider profile

Performance

Overall performance
1.4
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 12% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -50%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Shah Preetam's trades of Cidara Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-12 2024-03-11
PlS Planned sale
71,185 -19.8%
215.31
US$1,375,085 		71,185 -19.8% 215.31 US$1,375,085
2023-03-13 2023-03-13
PlS Planned sale
53,013 +35.8%
148.85
US$2,335,864 		53,013 +35.8% 148.85 US$2,335,864
2022-09-19 2022-09-19
S Sale
37,165 +49.5%
103.66
US$291,806 		37,165 +49.5% 103.66 US$291,806
2021-11-15 2021-11-12
B Purchase
20,000 +inf%
1.54
US$30,800 		20,000 +inf% 1.54 US$30,800